|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.535 SEK | +10.77% |
|
+11.46% | -54.27% |
| 04-19 | AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract | MT |
| 04-09 | AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas | MT |
AegirBio AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported negative sales was SEK 0.001 million compared to sales of SEK 0.006 million a year ago. Net loss was SEK 10.58 million compared to SEK 317.88 million a year ago.
Basic loss per share from continuing operations was SEK 0.4 compared to SEK 0.64 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -54.27% | 1.38M | |
| +12.06% | 225B | |
| +12.07% | 186B | |
| +13.88% | 135B | |
| +27.12% | 107B | |
| +0.91% | 63.56B | |
| +6.74% | 51.32B | |
| +13.39% | 51.04B | |
| +8.81% | 43.3B | |
| +4.14% | 36.99B |
AEGIRBIO AB 
